Ipca Laboratories Limited
IPCALAB
Rang în acțiuni
#3411
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Preț acțiune
$20.02
Ultima sincronizare: 2026-10-19
Capitalizare de piață
$5.08B
Schimbare (1 zi)
-1.65%
Schimbare (1 an)
38.46%
Țară
IN
Tranzacționează Ipca Laboratories Limited (IPCALAB)
Categorie
Healthcare
Raport P/S pentru Ipca Laboratories Limited (IPCALAB)
Raport P/S la data de October 2026 TTM: 4.79
Conform celor mai recente rapoarte financiare și prețului acțiunilor Ipca Laboratories Limited, raportul P/S actual (TTM) este 4.79. La sfârșitul anului 2024, compania avea un P/S de 4.09.
Istoricul raportului P/S pentru Ipca Laboratories Limited din 2005 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 4.79 | 21.18% |
| 2025 | 3.95 | -3.41% |
| 2024 | 4.09 | 23.36% |
| 2023 | 3.31 | -29.36% |
| 2022 | 4.69 | 4.36% |
| 2021 | 4.49 | 16.46% |
| 2020 | 3.86 | 15.92% |
| 2019 | 3.33 | 27.17% |
| 2018 | 2.62 | 2.84% |
| 2017 | 2.55 | -1.43% |
| 2016 | 2.58 | 0.29% |
| 2015 | 2.57 | -21.59% |
| 2014 | 3.28 | 37.60% |
| 2013 | 2.39 | 33.22% |
| 2012 | 1.79 | -9.72% |
| 2011 | 1.98 | -7.96% |
| 2010 | 2.16 | 233.52% |
| 2009 | 0.65 | -56.00% |
| 2008 | 1.47 | -8.30% |
| 2007 | 1.60 | 38.75% |
| 2006 | 1.15 | 4.46% |
| 2005 | 1.11 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 47.45% |
IN
|
